Financings In Brief
This article was originally published in The Gray Sheet
Opko Health offering nets $104.9 million
You may also be interested in...
Teleflex buys VasoNova
Business development leaders and venture capital investors spoke at Biocom’s annual partnering conference about what they are seeking in relationships with entrepreneurs and start-ups.
Mylan’s full year 2019 earnings report was its last as an independent company, so the focus was on the coming merger with Pfizer’s Upjohn and growth prospects for the new company, Viatris.